MDxHealth SA
MDXH
$0.69
-$0.02-3.01%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.27% | 19.43% | 20.06% | 22.48% | 20.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.27% | 19.43% | 20.06% | 22.48% | 20.50% |
| Cost of Revenue | 3.12% | 17.74% | 1.86% | 13.09% | 33.03% |
| Gross Profit | 1.83% | 20.43% | 32.22% | 28.53% | 13.72% |
| SG&A Expenses | 21.30% | 26.08% | -1.93% | 1.79% | 13.25% |
| Depreciation & Amortization | -4.85% | -5.79% | 17.54% | 17.51% | 17.64% |
| Other Operating Expenses | 124.78% | -146.71% | -1,302.50% | 6,855.56% | 8.33% |
| Total Operating Expenses | 13.28% | 18.60% | -2.77% | 9.24% | 22.99% |
| Operating Income | -166.13% | -14.19% | 73.30% | 30.53% | -33.57% |
| Income Before Tax | -21.70% | -54.57% | 32.44% | -6.59% | -7.96% |
| Income Tax Expenses | -- | -3,375.00% | -- | -- | -- |
| Earnings from Continuing Operations | -28.57% | -30.51% | 36.05% | -8.20% | -11.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.43% | -30.51% | 36.05% | -8.20% | -11.39% |
| EBIT | -166.13% | -14.19% | 73.30% | 30.53% | -33.57% |
| EBITDA | -1,153.24% | -16.81% | 95.98% | 50.23% | -46.29% |
| EPS Basic | -55.26% | -21.43% | 66.26% | 38.71% | -8.11% |
| Normalized Basic EPS | -378.81% | -322.58% | 85.31% | -- | -- |
| EPS Diluted | -55.26% | -21.43% | 66.26% | 38.71% | -8.11% |
| Normalized Diluted EPS | -378.81% | -322.58% | 85.31% | -- | -- |
| Average Basic Shares Outstanding | 0.76% | 7.48% | 89.54% | 76.54% | 3.03% |
| Average Diluted Shares Outstanding | 0.76% | 7.48% | 89.54% | 76.54% | 3.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |